explore -WSS

explore

author：leisure time 2025-09-30 08:59:39 - browse：5217

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

LONDON — Roche on Thursday said its recently acquired experimental obesity medication helped people lose a significant amount of weight in an early trial, sending its shares up in early trading.

The drug, a once-weekly injection known as CT-388, resulted in an average placebo-adjusted weight loss of 18.8% after 24 weeks, the company said. The study was a Phase 1 trial, though it was placebo-controlled.

The reaction to such an early result — Roche shares were up roughly 4% early Thursday — is a signal both of the stakes of the obesity medication race and the keen interest investors have in the field.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Coloradans with cystic fibrosis could lose access to Trikafta

WSS

Humans aren't the only ones with an imagination. Rats have it too

Titanic submersible: What a 'catastrophic implosion' means and what officials found

Gene therapy’s promise and the high cost of hope

How redistricting in 6 states could affect who controls Congress

The PBM ad wars are taking over Washington, D.C.

Gene therapy’s promise and the high cost of hope

Wikipedia

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

Affirmative action in medical school literally saved lives

Neutralizing antibodies against HIV shows promise in children

Medical records are filled with copy

UPS workers' union leader explains what's at stake as strike edges closer

United colonoscopy coverage change 'may cost lives,' doctors say

The PBM ad wars are taking over Washington, D.C.

How one medical school became remarkably diverse

Rare Northern Lights show in US this week: Where and how to see it

explore

US intelligence assessment says Iran not currently developing nuclear weapons

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

North Korean leader's powerful sister says warplanes repelled US spy plane

explore

focus

hotspot

explore